We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWF
1376
AllianceBernstein Global High Income Fund
AWF
$872M
$137K ﹤0.01%
11,435
+12
+0.1% +$148
RLD
1377
DELISTED
REALD INC COM STK
RLD
$136K ﹤0.01%
+11,000
New +$138K
AFB
1378
AllianceBernstein National Municipal Income Fund
AFB
$314M
$135K ﹤0.01%
10,250
-4,150
-29% -$55.6K
BHK icon
1379
BlackRock Core Bond Trust
BHK
$644M
$131K ﹤0.01%
10,380
-9,621
-48% -$129K
CLMS
1380
DELISTED
Calamos Asset Management, Inc.
CLMS
$131K ﹤0.01%
+10,683
New +$132K
NZH
1381
DELISTED
Nuveen Calif Div
NZH
$131K ﹤0.01%
10,271
-2,835
-22% -$38K
FUEL
1382
DELISTED
Rocket Fuel Inc.
FUEL
$130K ﹤0.01%
15,885
-800
-5% -$6.86K
NHS
1383
Neuberger High Yield Strategies Fund Inc
NHS
$252M
$125K ﹤0.01%
10,661
-5,000
-32% -$61.4K
C.WS.A
1384
DELISTED
Citigroup Inc
C.WS.A
$125K ﹤0.01%
169,000
IRIX icon
1385
IRIDEX
IRIX
$14.5M
$124K ﹤0.01%
15,000
TCRT icon
1386
Alaunos Therapeutics
TCRT
$4.59M
$123K ﹤0.01%
68
+1
+1% +$1.55K
SZMK
1387
DELISTED
SIZMEK INC COM STK (DE)
SZMK
$122K ﹤0.01%
17,250
STEW
1388
SRH Total Return Fund
STEW
$1.78B
$121K ﹤0.01%
14,329
PTX
1389
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$121K ﹤0.01%
2,035
+1,025
+101% +$72.3K
DXLG icon
1390
Destination XL Group
DXLG
$29.3M
$119K ﹤0.01%
+23,700
New +$118K
AG icon
1391
First Majestic Silver
AG
$7.73B
$118K ﹤0.01%
24,467
-132
-0.5% -$670
RKUS
1392
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$118K ﹤0.01%
11,411
-8,425
-42% -$96.5K
AUDC icon
1393
AudioCodes
AUDC
$235M
$117K ﹤0.01%
36,000
+15,970
+80% +$67.6K
AU icon
1394
AngloGold Ashanti
AU
$41.6B
$116K ﹤0.01%
13,000
-2,000
-13% -$20.3K
OXSQ icon
1395
Oxford Square Capital
OXSQ
$151M
$115K ﹤0.01%
16,994
+1,300
+8% +$8.96K
BTU
1396
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$113K ﹤0.01%
3,451
+1,044
+43% +$61.1K
DSM
1397
BNY Mellon Strategic Municipal Bond Fund
DSM
$288M
$110K ﹤0.01%
14,310
-10,941
-43% -$86.5K
NUWE icon
1398
Nuwellis
NUWE
$410K
0
ATEN icon
1399
A10 Networks
ATEN
$2.16B
$108K ﹤0.01%
16,816
-19,651
-54% -$110K
EMD
1400
DELISTED
Western Asset Emerging Markets
EMD
$107K ﹤0.01%
10,000

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.